Page last updated: 2024-11-02

oxybutynin and Peripheral Vascular Diseases

oxybutynin has been researched along with Peripheral Vascular Diseases in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.

Research Excerpts

ExcerptRelevanceReference
"Twenty patients with ESRD were treated with Qutenza® for neuropathic pain from critical limb ischemia."5.46The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study. ( Aitken, E; Kingsmore, D; McColl, G, 2017)
"Twenty patients with ESRD were treated with Qutenza® for neuropathic pain from critical limb ischemia."1.46The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study. ( Aitken, E; Kingsmore, D; McColl, G, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aitken, E1
McColl, G1
Kingsmore, D1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randonimised Trial Comparing Interrupted to Continuous Suturing Techniques in Radiocephalic Fistulae[NCT01704313]70 participants (Anticipated)Interventional2012-05-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for oxybutynin and Peripheral Vascular Diseases

ArticleYear
The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study.
    Pain medicine (Malden, Mass.), 2017, 02-01, Volume: 18, Issue:2

    Topics: Administration, Topical; Adult; Aged; Capsaicin; Cohort Studies; Female; Humans; Ischemia; Kidney Fa

2017